本页面由Tiger Trade Technology Pte. Ltd.提供服务

Abeona Therapeutics Inc

4.52
-0.3800-7.76%
盘后:4.570.0500+1.11%16:31 EDT
成交量:179.47万
成交额:828.41万
市值:2.58亿
市盈率:-4.04
高:4.88
开:4.88
低:4.51
收:4.90
52周最高:7.65
52周最低:4.00
股本:5,704.90万
流通股本:3,691.95万
量比:1.54
换手率:4.86%
股息:- -
股息率:- -
每股收益(TTM):-1.1200
每股收益(LYR):1.01
净资产收益率:-43.13%
总资产收益率:-24.55%
市净率:2.01
市盈率(LYR):4.48

数据加载中...

2026/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/20

重要事件披露

Form 8-K - Current report
2026/03/17

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities